𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3

✍ Scribed by C. Mathieu; M. Waer; J. Laureys; O. Rutgeerts; R. Bouillon


Publisher
Springer
Year
1994
Tongue
English
Weight
794 KB
Volume
37
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

✦ Synopsis


1,25 dihydroxyvitamin D3, the active form of vitamin D, has immunomodulatory properties in vitro and in vivo. We report that treatment with 1,25 dihydroxyvitamin 03 (5 gg/kg on alternate days) prevents the development of clinical diabetes in NOD mice, an animal model of human autoimmune diabetes. Diabetes incidence in female NOD mice at the age of 200 days was reduced to 8 % in the 1,25 dihydroxyvitamin D treated group vs 56% in the control group (p < 0.0001). In parallel, treatment with 1,25 dihydroxyvitamin D 3 resulted in a complete normalisation of the capacity to induce suppressor mechanisms in an autologous MLR, which is severely depressed in control NOD mice. The existence of such suppressor ceils was confirmed in transfer experiments, whereby cotransfer of splenocytes from 1,25 dihydroxyvitamin D3 treated NOD mice prevented diabetes transfer by splenocytes from diabetic NOD mice into irradiated, 6-8-week-old male NOD mice. Other known immune defects of the NOD mice, such as defective natural killer cell killing of YAC-1 targets and defective thymocyte activation by anti-CD3 were not corrected. The pharmacological doses of 1,25 dihydroxyvitamin D3 were universally well tolerated as reflected by a normal weight gain of the mice. Serum calcium was increased (2.5+0.2 vs 2.2 + 0.2 mmol/1 in the control group,p < 0.005), whereas osteocalcin levels nearly doubled and bone calcium content was halved. These findings show that 1,25 dihydroxyvitamin D3 can prevent diabetes in NOD mice, probably through the correction of their defective suppressor function. [Diabetologia (1994) 37: 552-558] Key words Autoimmunity, immunotherapy, suppressor cells, insulitis, vitamin D analogues The NOD mouse is an animal model for human autoimmune diabetes (IDDM or juvenile diabetes), characterized by destruction of the insulin producing beta cells of the islets of Langerhans in the pancreas. The precise immune mechanisms leading to this destruction remain unclear [1-3]. Defective elimination of autoreactive T-cell clones or impaired suppressor mechanisms are the most acceptable hypotheses [4]. Conse-


πŸ“œ SIMILAR VOLUMES


Synthesis of 1,25-dihydroxyvitamin D3 by
✍ I. Neveu; P. Naveilhan; C. Menaa; D. Wion; Dr. P. Brachet; M. GarabΓ©dian πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 696 KB

Cultured microglial cells were examined for their ability to metabolize 25-hydroxyvitamin D, (25-(OH) D,). Upon exposure to lipopolysaccharide, microglial cells produced a vitamin D metabolite which comigrated with synthetic 1,25-dihydroxyvitamin D, (1,25-(OH),D,) in two different systems of high pe

Protection against cyclophosphamide-indu
✍ Guan Chen; Alec Baechle; Thomas D. Nevins; Susan Oh; Charles Harmon; Dennis W. S πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 227 KB πŸ‘ 2 views

Twenty-one-day-old BALB/c mice were shaved on the back to synchronize hair growth. On day 30 or 31, when at least 90% of mice exhibited hair regrowth in the shaved area, 1,25(OH)2D3 was applied topically to the shaved area daily for 5 days. On the 6th day, cyclophosphamide (Cytoxan, CTX) was injecte

1,25-dihydroxyvitamin D3 reverses experi
✍ Laura B. Pedersen; Faye E. Nashold; Karen M. Spach; Colleen E. Hayes πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 607 KB

## Abstract Multiple sclerosis (MS) is a complex neurodegenerative disease whose pathogenesis involves genetic and environmental risk factors leading to an aberrant, neuroantigen‐specific, CD4^+^ T cell‐mediated autoimmune response. In support of the hypothesis that vitamin D~3~ may reduce MS risk